Skip to main content

Table 2 Changes in clinical serum chemistry and complete blood count variables

From: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion

Variable

Group

Day 0

Day 28

Significance

Triglycerides

(mg·dl-1)

TD

PLA

94 ± 8

94 ± 7

105 ± 9

98 ± 7

Group:

Time:

G × T:

0.77

0.10

0.44

Total Chol

(mg·dl-1)

TD

PLA

162 ± 5

165 ± 6

164 ± 5

168 ± 5

Group:

Time:

G × T:

0.61

0.32

0.99

HDL Chol

(mg·dl-1)

TD

PLA

58 ± 3

54 ± 2

57 ± 3

54 ± 2

Group:

Time:

G × T:

0.33

0.92

0.44

LDL Chol

(mg·dl-1)

TD

PLA

85 ± 4

94 ± 6

86 ± 5

94 ± 5

Group:

Time:

G × T:

0.26

0.73

0.91

Glucose

(mg·dl-1)

TD

PLA

94 ± 1

91 ± 1

96 ± 1

92 ± 1

Group:

Time:

G × T:

0.07

0.06

0.52

Sodium

(mM)

TD

PLA

141 ± 1

141 ± 1

142 ± 2

142 ± 2

Group:

Time:

G × T:

0.93

0.03

0.96

Potassium

(mM)

TD

PLA

4.4 ± 0.1

4.5 ± 0.1

4.5 ± 0.1

4.6 ± 0.1

Group:

Time:

G × T:

0.20

0.41

0.96

BUN

(mg·dl-1)

TD

PLA

14 ± 1

14 ± 1

14 ± 1

13 ± 1

Group:

Time:

G × T:

0.63

0.35

0.36

Creatinine

(mg·dl-1)

TD

PLA

1.0 ± 0.0

1.0 ± 0.0

1.0 ± 0.0

1.0 ± 0.0

Group:

Time:

G × T:

0.46

0.007

0.42

ALT

(U·L-1)

TD

PLA

20 ± 2

19 ± 1

18 ± 1

18 ± 1

Group:

Time:

G × T:

0.69

0.12

0.51

AST

(U·L-1)

TD

PLA

20 ± 1

20 ± 1

20 ± 1

21 ± 2

Group:

Time:

G × T:

0.94

0.53

0.74

RBC Count

(106·μl-1)

TD

PLA

5.00 ± 0.12

4.91 ± 0.14

4.63 ± 0.08

4.62 ± 0.10

Group:

Time:

G × T:

0.75

< 0.001

0.68

Hemoglobin

(g·dl-1)

TD

PLA

14.5 ± 0.2

14.8 ± 0.3

14.2 ± 0.2

14.4 ± 0.3

Group:

Time:

G × T:

0.42

0.003

0.50

Hematocrit

(%)

TD

PLA

43.6 ± 1.6

42.7 ± 0.8

40.8 ± 0.7

41.0 ± 0.9

Group:

Time:

G × T:

0.78

0.02

0.56

WBC Count

(103·μl-1)

TD

PLA

5.9 ± 0.2

5.9 ± 0.2

5.8 ± 0.2

6.1 ± 0.2

Group:

Time:

G × T:

0.63

0.95

0.36

  1. TD, thermogenic drink group (n = 30)
  2. PLA, placebo group (n = 30)
  3. Values are expressed as means ± SE
  4. Significant main effect for time, p < 0.05